Increased reporting of interstitial pneumonitis with combined EGFR-TKI and PD-1/PD-L1 inhibitor therapy in NSCLC: a pharmacovigilance analysis of 67,818 reports - Jinyi Tao; Zhiwen Fu (Frontiers in Immunology, 2026)